Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Pilot study of resveratrol in older adults with impaired glucose tolerance.

Crandall JP, Oram V, Trandafirescu G, Reid M, Kishore P, Hawkins M, Cohen HW, Barzilai N.

J Gerontol A Biol Sci Med Sci. 2012 Dec;67(12):1307-12. doi: 10.1093/gerona/glr235. Epub 2012 Jan 4.

2.

Resveratrol Improves Vascular Function and Mitochondrial Number but Not Glucose Metabolism in Older Adults.

Pollack RM, Barzilai N, Anghel V, Kulkarni AS, Golden A, O'Broin P, Sinclair DA, Bonkowski MS, Coleville AJ, Powell D, Kim S, Moaddel R, Stein D, Zhang K, Hawkins M, Crandall JP.

J Gerontol A Biol Sci Med Sci. 2017 Nov 9;72(12):1703-1709. doi: 10.1093/gerona/glx041.

PMID:
28329397
4.

Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.

Henkel E, Menschikowski M, Koehler C, Leonhardt W, Hanefeld M.

Metabolism. 2005 Sep;54(9):1168-73.

PMID:
16125528
5.

Post-challenge hyperglycemia in older adults is associated with increased cardiovascular risk profile.

Crandall JP, Shamoon H, Cohen HW, Reid M, Gajavelli S, Trandafirescu G, Tabatabaie V, Barzilai N.

J Clin Endocrinol Metab. 2009 May;94(5):1595-601. doi: 10.1210/jc.2008-1829. Epub 2009 Feb 10.

6.

Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects.

Miyazaki Y, Akasaka H, Ohnishi H, Saitoh S, DeFronzo RA, Shimamoto K.

Hypertens Res. 2008 Jul;31(7):1357-63. doi: 10.1291/hypres.31.1357.

PMID:
18957806
7.

Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.

Kanat M, Norton L, Winnier D, Jenkinson C, DeFronzo RA, Abdul-Ghani MA.

Acta Diabetol. 2011 Sep;48(3):209-17. doi: 10.1007/s00592-011-0285-x. Epub 2011 May 8.

PMID:
21553243
8.

L-arginine enriched biscuits improve endothelial function and glucose metabolism: a pilot study in healthy subjects and a cross-over study in subjects with impaired glucose tolerance and metabolic syndrome.

Monti LD, Casiraghi MC, Setola E, Galluccio E, Pagani MA, Quaglia L, Bosi E, Piatti P.

Metabolism. 2013 Feb;62(2):255-64. doi: 10.1016/j.metabol.2012.08.004. Epub 2012 Oct 3.

PMID:
23040413
9.

Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.

Hung YJ, Lin SH, Pei D, Kuo SW, Hsieh CH, He CT, Hsing Lee C, Fan SC, Sheu WH.

Metabolism. 2006 Apr;55(4):439-44.

PMID:
16546473
10.

Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.

Rask E, Olsson T, Söderberg S, Holst Jj Jj, Tura A, Pacini G, Ahrén B.

Metabolism. 2004 May;53(5):624-31.

PMID:
15131768
11.

Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls.

Neri S, Signorelli SS, Torrisi B, Pulvirenti D, Mauceri B, Abate G, Ignaccolo L, Bordonaro F, Cilio D, Calvagno S, Leotta C.

Clin Ther. 2005 Nov;27(11):1764-73.

PMID:
16368447
12.

The disposition index does not reflect β-cell function in IGT subjects treated with pioglitazone.

DeFronzo RA, Tripathy D, Abdul-Ghani M, Musi N, Gastaldelli A.

J Clin Endocrinol Metab. 2014 Oct;99(10):3774-81. doi: 10.1210/jc.2014-1515. Epub 2014 Jun 17.

PMID:
24937535
13.

Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects.

Matsumoto K, Miyake S, Yano M, Ueki Y, Yamaguchi Y, Akazawa S, Tominaga Y.

Diabetes Care. 1997 Oct;20(10):1562-8.

PMID:
9314636
14.

Insulin sensitivity and secretion in Arab Americans with glucose intolerance.

Salinitri FD, Pinelli NR, Martin ET, Jaber LA.

Diabetes Technol Ther. 2013 Dec;15(12):1019-24. doi: 10.1089/dia.2013.0045. Epub 2013 Aug 6.

15.

The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance.

Abdul-Ghani MA, Matsuda M, Jani R, Jenkinson CP, Coletta DK, Kaku K, DeFronzo RA.

Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E401-6. doi: 10.1152/ajpendo.00674.2007. Epub 2008 May 20.

16.

Mild fasting hyperglycemia shifts fuel reliance toward fat during exercise in adults with impaired glucose tolerance.

Malin SK, Viskochil R, Oliver C, Braun B.

J Appl Physiol (1985). 2013 Jul 1;115(1):78-83. doi: 10.1152/japplphysiol.00084.2013. Epub 2013 Apr 18.

17.

Dietary treatment with rice containing resistant starch improves markers of endothelial function with reduction of postprandial blood glucose and oxidative stress in patients with prediabetes or newly diagnosed type 2 diabetes.

Kwak JH, Paik JK, Kim HI, Kim OY, Shin DY, Kim HJ, Lee JH, Lee JH.

Atherosclerosis. 2012 Oct;224(2):457-64. doi: 10.1016/j.atherosclerosis.2012.08.003. Epub 2012 Aug 27.

PMID:
22954674
18.

Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance.

Garcia AL, Otto B, Reich SC, Weickert MO, Steiniger J, Machowetz A, Rudovich NN, Möhlig M, Katz N, Speth M, Meuser F, Doerfer J, Zunft HJ, Pfeiffer AH, Koebnick C.

Eur J Clin Nutr. 2007 Mar;61(3):334-41. Epub 2006 Sep 20.

PMID:
16988651
19.

Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.

Snehalatha C, Ramachandran A, Satyavani K, Latha E, Viswanathan V.

Diabetes Care. 1998 Jan;21(1):76-9.

PMID:
9538973

Supplemental Content

Support Center